New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Feb 2023
Historique:
received: 05 12 2022
revised: 03 02 2023
accepted: 06 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Iron oxide nanoparticles are one of the most promising tools for theranostic applications of pancreatic cancer due to their unique physicochemical and magnetic properties making them suitable for both diagnosis and therapy. Thus, our study aimed to characterize the properties of dextran-coated iron oxide nanoparticles (DIO-NPs) of maghemite (γ-Fe

Identifiants

pubmed: 36834718
pii: ijms24043307
doi: 10.3390/ijms24043307
pmc: PMC9965009
pii:
doi:

Substances chimiques

Dextrans 0
Pancreatic Hormones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cold Spring Harb Perspect Biol. 2019 Sep 3;11(9):
pubmed: 30745292
Int J Nanomedicine. 2017 Jul 24;12:5223-5238
pubmed: 28769560
Nanoscale. 2017 Aug 31;9(34):12735-12745
pubmed: 28829476
J Biomed Nanotechnol. 2015 Jan;11(1):126-36
pubmed: 26301306
Talanta. 2012 May 30;94:348-52
pubmed: 22608459
Cancer Biol Med. 2021 Apr 16;:
pubmed: 33861527
Cancers (Basel). 2021 Aug 14;13(16):
pubmed: 34439250
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):443-451
pubmed: 32024389
Heliyon. 2018 Dec 17;4(12):e01055
pubmed: 30582059
Sci Rep. 2018 Feb 1;8(1):2082
pubmed: 29391477
Int J Mol Sci. 2021 Jul 28;22(15):
pubmed: 34360829
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jul;14(4):e1793
pubmed: 35396932
Biomaterials. 2011 Dec;32(35):9155-8
pubmed: 21963282
Molecules. 2020 Jul 10;25(14):
pubmed: 32664325
J Leukoc Biol. 2012 Nov;92(5):951-8
pubmed: 22859832
Oxid Med Cell Longev. 2016;2016:6235641
pubmed: 27418953
Semin Oncol. 2019 Feb;46(1):39-47
pubmed: 30611527
Chem Cent J. 2012 Mar 13;6:17
pubmed: 22410001
Methods Mol Biol. 2013;1028:155-64
pubmed: 23740119
Sci Rep. 2016 Feb 17;6:21648
pubmed: 26884312
J Control Release. 2009 Dec 16;140(3):301-5
pubmed: 19508879
Cell Death Dis. 2018 Feb 7;9(2):161
pubmed: 29415987
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Protein Pept Lett. 2009;16(6):571-81
pubmed: 19519514
Quant Imaging Med Surg. 2017 Feb;7(1):88-122
pubmed: 28275562
Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302
pubmed: 19249331
ACS Nano. 2013 Mar 26;7(3):2078-89
pubmed: 23402593
Polymers (Basel). 2022 Apr 29;14(9):
pubmed: 35566991
Asia Pac J Clin Oncol. 2016 Mar;12(1):13-21
pubmed: 26663873
Nanoscale. 2013 Dec 7;5(23):11428-37
pubmed: 23963338
Int J Nanomedicine. 2012;7:5053-65
pubmed: 23028227
BMC Neurosci. 2017 Jun 26;18(1):51
pubmed: 28651647
ACS Biomater Sci Eng. 2021 Dec 13;7(12):5432-5450
pubmed: 34786932
Front Bioeng Biotechnol. 2019 Nov 13;7:307
pubmed: 31824928
Curr Health Sci J. 2017 Apr-Jun;43(2):132-136
pubmed: 30595868
Nanoscale Res Lett. 2012 Oct 22;7(1):576
pubmed: 23088756
Biomacromolecules. 2017 Feb 13;18(2):490-497
pubmed: 28052673
Int J Nanomedicine. 2012;7:3445-71
pubmed: 22848170
Molecules. 2020 Oct 15;25(20):
pubmed: 33076247
Molecules. 2022 Jun 21;27(13):
pubmed: 35807217
EBioMedicine. 2019 Feb;40:39-40
pubmed: 30765320
Contrast Media Mol Imaging. 2009 Nov-Dec;4(6):299-304
pubmed: 19998319
Innate Immun. 2014 Feb;20(2):115-25
pubmed: 23676582
ACS Nano. 2015 Aug 25;9(8):7976-91
pubmed: 26242412
J Oncol Pract. 2016 Sep;12(9):772-8
pubmed: 27621326
Biomed Res Int. 2014;2014:134260
pubmed: 24949417
Environ Mol Mutagen. 2015 Mar;56(2):125-48
pubmed: 25209650
Materials (Basel). 2019 Mar 29;12(7):
pubmed: 30934985
J Am Chem Soc. 2010 Dec 8;132(48):17227-35
pubmed: 21077674
Oxid Med Cell Longev. 2020 Feb 27;2020:9369524
pubmed: 32190179
Nat Rev Clin Oncol. 2015 Jun;12(6):319-34
pubmed: 25824606
Biomaterials. 2012 Jan;33(1):163-70
pubmed: 22027595
Ann Clin Lab Sci. 1985 Jan-Feb;15(1):13-31
pubmed: 3882046
Heliyon. 2022 Jun 06;8(6):e09654
pubmed: 35711994
J Am Chem Soc. 2010 Jun 23;132(24):8246-7
pubmed: 20504022
Cancers (Basel). 2022 Mar 16;14(6):
pubmed: 35326675
Gut. 2016 Nov;65(11):1838-1849
pubmed: 27196585
Part Fibre Toxicol. 2022 Mar 29;19(1):24
pubmed: 35351185
Biochem Biophys Rep. 2018 Jan 08;13:63-72
pubmed: 29349357

Auteurs

Mihaela Balas (M)

Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.

Daniela Predoi (D)

National Institute of Materials Physics, 076900 Magurele, Romania.

Carmen Burtea (C)

Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, Avenue Maistriau 19, Mendeleïev Building, B-7000 Mons, Belgium.

Anca Dinischiotu (A)

Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH